東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Biominetic High Density Lipoproteins...

Tripathy, Sushant.

Linked to FindBook

Google Book

Amazon

博客來

Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides./
Author:	Tripathy, Sushant.
Description:	110 p.
Notes:	Source: Dissertation Abstracts International, Volume: 76-10(E), Section: B.
Contained By:	Dissertation Abstracts International76-10B(E).
Subject:	Nanoscience. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3705384
ISBN:	9781321783216

Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides.
Tripathy, Sushant.

Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides. - 110 p.

Source: Dissertation Abstracts International, Volume: 76-10(E), Section: B.

Thesis (Ph.D.)--Northwestern University, 2015.

Advances in nanotechnology have brought about novel inorganic and hybrid nanoparticles with unique physico-chemical properties that make them suitable for a broad range of applications---from nano-circuitry to drug delivery. A significant part of those advancements have led to ground-breaking discoveries that have changed the approaches to formulation of therapeutics against diseases, such as cancer. Now-a-days the focus does not lie solely on finding a candidate small-molecule therapeutic with minimal adverse effects, but researchers are looking up to nanoparticles to improve biodistribution and biocompatibility profile of clinically proven therapeutics. The plethora of conjugation chemistries offered by currently extant inorganic nanoparticles have, in recent years, led to great leaps in the field of biomimicry---a modality that promises high biocompatibility. Further, in the pursuit of highly specific therapeutic molecules, researchers have turned to silencing oligonucleotides and some have already brought together the strengths of nanoparticles and silencing oligonucleotides in search of an efficacious therapy for cancer with minimal adverse effects. This dissertation work focuses on such a biomimetic platform---a gold nanoparticle based high density lipoprotein biomimetic (HDL NP), for the delivery of therapeutic oligonucleotides.

ISBN: 9781321783216Subjects--Topical Terms:

587832
Nanoscience.

Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides.
LDR:03148nmm a2200301 4500 001 2077487
005 20161114130318.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781321783216
035 $a (MiAaPQ)AAI3705384
035 $a AAI3705384
040 $a MiAaPQ $c MiAaPQ
100 1 $a Tripathy, Sushant. $3 3192990
245 1 0 $a Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides.
300 $a 110 p.
500 $a Source: Dissertation Abstracts International, Volume: 76-10(E), Section: B.
500 $a Advisers: Colby S. Thaxton; Olga V. Volpert.
502 $a Thesis (Ph.D.)--Northwestern University, 2015.
520 $a Advances in nanotechnology have brought about novel inorganic and hybrid nanoparticles with unique physico-chemical properties that make them suitable for a broad range of applications---from nano-circuitry to drug delivery. A significant part of those advancements have led to ground-breaking discoveries that have changed the approaches to formulation of therapeutics against diseases, such as cancer. Now-a-days the focus does not lie solely on finding a candidate small-molecule therapeutic with minimal adverse effects, but researchers are looking up to nanoparticles to improve biodistribution and biocompatibility profile of clinically proven therapeutics. The plethora of conjugation chemistries offered by currently extant inorganic nanoparticles have, in recent years, led to great leaps in the field of biomimicry---a modality that promises high biocompatibility. Further, in the pursuit of highly specific therapeutic molecules, researchers have turned to silencing oligonucleotides and some have already brought together the strengths of nanoparticles and silencing oligonucleotides in search of an efficacious therapy for cancer with minimal adverse effects. This dissertation work focuses on such a biomimetic platform---a gold nanoparticle based high density lipoprotein biomimetic (HDL NP), for the delivery of therapeutic oligonucleotides.
520 $a The first chapter of this body of work introduces the molecular target of the silencing oligonucleotides---VEGFR2, and its role in the progression of solid tumor cancers. The background information also covers important aspects of natural high density lipoproteins (HDL), especially their innate capacity to bind and deliver exogenous and endogenous silencing oligonucleotides to tissues that express their high affinity receptor SRB1. We subsequently describe the synthesis of the biomimetic HDL NP and its oligonucleotide conjugates, and establish their biocompatibility. Further on, experimental data demonstrate the efficacy of silencing oligonucleotides conjugated HDL NPs in regulating the expression and function of VEGFR2 in cultured endothelial cells. Finally, the efficacy of the conjugates in two animal models of angiogenesis is presented.
590 $a School code: 0163.
650 4 $a Nanoscience. $3 587832
650 4 $a Cellular biology. $3 3172791
650 4 $a Oncology. $3 751006
690 $a 0565
690 $a 0379
690 $a 0992
710 2 $a Northwestern University. $b Integrated Graduate Program in the Life Sciences. $3 1682749
773 0 $t Dissertation Abstracts International $g 76-10B(E).
790 $a 0163
791 $a Ph.D.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3705384